Importer of Controlled Substances Registration: Mylan Technologies, Inc., 22314 [2016-08846]
Download as PDF
<![CDATA[
22314
Federal Register / Vol. 81, No. 73 / Friday, April 15, 2016 / Notices
reply submissions, if any, are limited to
75 pages.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to section
210.4(f) of the Commission’s Rules of
Practice and Procedure (19 CFR
210.4(f)). Submissions should refer to
the investigation number (‘‘Inv. No.
337–TA–944’’) in a prominent place on
the cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, https://www.usitc.gov/
secretary/fed_reg_notices/rules/
handbook_on_electronic_filing.pdf).
Persons with questions regarding filing
should contact the Secretary (202–205–
2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. A redacted nonconfidential version of the document
must also be filed simultaneously with
the any confidential filing. All nonconfidential written submissions will be
available for public inspection at the
Office of the Secretary and on EDIS.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: April 11, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016–08680 Filed 4–14–16; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
By notice
dated November 27, 2015, and
published in the Federal Register on
December 3, 2015, 80 FR 75688, Mylan
Technologies, Inc., 110 Lake Street,
Saint Albans, Vermont 05478 applied to
be registered as an importer of certain
basic classes of controlled substances.
No comments or objections were
submitted for this notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Mylan Technologies, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the following basic classes
of controlled substances:
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection Reporting and
Recordkeeping for Digital Certificates
SUPPLEMENTARY INFORMATION:
Controlled substance
Methylphenidate (1724) ................
Fentanyl (9801) ............................
Schedule
II
II
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domesticallymanufactured FDF to foreign markets.
Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
Drug Enforcement Administration
[Docket No. DEA–392]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Administration (DEA) grants Mylan
Technologies, Inc. registration as an
importer of those controlled substances.
[FR Doc. 2016–08846 Filed 4–14–16; 8:45 am]
Importer of Controlled Substances
Registration: Mylan Technologies, Inc.
ACTION:
BILLING CODE 4410–09–P
Notice of registration.
Mylan Technologies, Inc.
applied to be registered as an importer
of certain basic classes of controlled
substances. The Drug Enforcement
SUMMARY:
VerDate Sep<11>2014
17:27 Apr 14, 2016
Jkt 238001
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
[OMB Number 1117–0038]
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the Federal
Register at 81 FR 7592, on February 12,
2016, allowing for a 60 day comment
period.
SUMMARY:
Comments are encouraged and
will be accepted for an additional 30
days until May 16, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Barbara J. Boockholdt, Office of
Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
Written comments and/or suggestions
can also be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503 or sent
to OIRA_submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
DATES:
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 81, Number 73 (Friday, April 15, 2016)]
[Notices]
[Page 22314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08846]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Mylan
Technologies, Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Mylan Technologies, Inc. applied to be registered as an
importer of certain basic classes of controlled substances. The Drug
Enforcement Administration (DEA) grants Mylan Technologies, Inc.
registration as an importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated November 27, 2015, and
published in the Federal Register on December 3, 2015, 80 FR 75688,
Mylan Technologies, Inc., 110 Lake Street, Saint Albans, Vermont 05478
applied to be registered as an importer of certain basic classes of
controlled substances. No comments or objections were submitted for
this notice.
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of Mylan Technologies, Inc.
to import the basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above-named company is granted
registration as an importer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Methylphenidate (1724)..................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
finished dosage form (FDF) from foreign sources for analytical testing
and clinical trials in which the foreign FDF will be compared to the
company's own domestically-manufactured FDF. This analysis is required
to allow the company to export domestically-manufactured FDF to foreign
markets.
Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-08846 Filed 4-14-16; 8:45 am]
BILLING CODE 4410-09-P
